The Leukemia & Lymphoma Society's (LLS's) Oversight Committees are comprised of leading experts in their fields. Committee members are volunteers who give their time and talent to LLS and receive no compensation for their generous support.
 

Therapy Acceleration Program Committee

Provides oversight and guidance on LLS’s Therapy Acceleration Program (TAP), a strategic venture philanthropy initiative through which LLS partners directly with biotechnology companies and medical institutions to help accelerate the development of promising therapies
 

Casey Cunningham, MD (Chair) +
Santé Ventures

Dana Callow, MBA +
Boston Millennia Partners

Giulio Draetta, MD, PhD
The University of Texas MD Anderson Cancer Center

Christoper Flowers, MD, MS, FASCO +
The University of Texas MD Anderson Cancer Center

Laura Kaufman, PhD, DABT
Private Consultant

Ronald Levy, MD
Stanford University School of Medicine

Vern Norviel, Esq.
Wilson Sonsini Goodrich & Rosati

Susan M. O’Brien, MD
UC Irvine Health

Robert Rosen, JD +
Grewhawke Capital Advisors

Steven Rosen, MD, FACP +
City of Hope

David Weinstock, MD
Dana-Farber Cancer Institute

+ National Board Member